During the past decade, Wellmont Medical Associates Oncology and Hematology-Kingsport conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wellmont Medical Associates Oncology and Hematology-Kingsport" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "SWOG Cancer Research Network" with 2 trials sponsored, "Academic and Community Cancer Research United" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wellmont Medical Associates Oncology and Hematology-Kingsport" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Pharma Consulting Group AB" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Wellmont Medical Associates Oncology and Hematology-Kingsport" are "Adult Cholangiocarcinoma" (1 trials), "Advanced Adult Hepatocellular Carcinoma" (1 trials), "Advanced Metastatic (Stage IV) Colorectal Cancer" (1 trials), "Arthralgia" (1 trials) and "BCLC Stage C Adult Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Wellmont Medical Associates Oncology and Hematology-Kingsport" in a lesser frequency.

Most popular intervention types in "Wellmont Medical Associates Oncology and Hematology-Kingsport" are "Drug" (11 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "Cisplatin" (2 trials), "Placebo" (2 trials), "Regorafenib" (2 trials) and "BTZ" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wellmont Medical Associates Oncology and Hematology-Kingsport" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wellmont Medical Associates Oncology and Hematology-Kingsport". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Wellmont Medical Associates Oncology and Hematology-Kingsport, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wellmont Medical Associates Oncology and Hematology-Kingsport, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".